TC Energy files 2025 annual disclosure documentsCALGARY, Alberta, Feb. 13, 2026 (GLOBE NEWSWIRE) -- News Release -- TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) has today filed with Canadian securities authorities:
Gildan Activewear Announces Date for Fourth Quarter 2025 Financial ResultsMONTREAL, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL; TSX and NYSE) will report its 2025 fourth quarter and full year results on Thursday, February 26, 2026. A press release will be issued before markets open, and a conference call is scheduled on that same day at 8:30 AM ET to discuss the Company’s results.
HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights- Cash position of US$195 million as of December 31, 2025, before adjustment for post quarter events -- Topline data readout from the Phase 2 study evaluating HLP004 in generalized anxiety disorder (“GAD”) expected in Q1 2026 -
Amid a Positive Outlook, Multiple Crypto Investment Institutions Complete US$60 Million Capital Injection into Jiuzi Holdings, Increasing the Original Planned Amount by 50%; JZXN’s DAT Strategy Enters Scaled Implementation PhaseHANGZHOU, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Jiuzi Holdings, Inc. (Nasdaq: JZXN) (the “Company”) today announced that it has entered into a definitive Securities Purchase Agreement (SPA) with multiple strategic investment institutions holding leading influence in the fields of crypto treasury management and digital asset allocation. Pursuant to the terms of the agreement, the investors will subscribe to 40,000,000 ordinary shares of the Company at $1.50 per share, for an aggregate transaction value of approximately $60 million, to be injected in the form of equivalent crypto assets. The signing of the agreement was announced on February 12, 2026.
Ampersand Capital Partners Named a Top Growth Equity Firm of 2025 by GrowthCapBoston, MA, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Ampersand Capital Partners, a private equity firm focused on growth-oriented investments in the life sciences and healthcare sectors, announced that it has been named one of GrowthCap’s Top Growth Equity Firms of 2025.
Medicenna Announces Changes to Board CompositionTORONTO and HOUSTON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announces that Mr. Richard Sutin and Mr. Angelos Georgakis have been appointed, effective as of February 12, 2026, to the board of directors of the Company (the “Board”).
Aurora Mobile’s GPTBots.ai Integrates GLM-5, Setting New Standards for Enterprise AI Performance and ValueHONG KONG, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (
NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services, today announced that its enterprise-grade AI agent platform, GPTBots.ai, has integrated the groundbreaking GLM-5 series model. This integration empowers enterprise users with unprecedented levels of AI performance, reliability, and real-world productivity—delivered instantly through the GPTBots.ai platform.
Gogo to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026BROOMFIELD, Colo., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (
NASDAQ: GOGO), the leading global provider of broadband connectivity services for the business aviation, military, and government markets, announced today that it will release its fourth quarter and full 2025 year financial results before the market opens on February 27, 2026. The Company will host a conference call with financial analysts the same day at 8:30 a.m. (EST).
Amplify ETFs Files for Amplify Municipal CEF High Income ETF (YYYM)CHICAGO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Amplify ETFs, a leading provider of breakthrough ETF solutions, announces the filing of the Amplify Municipal CEF High Income ETF (YYYM).
SPARC AI Enhances Overwatch with AI Telemetry Optimization to Reduce Drift and Improve Mission ReliabilityVANCOUVER, British Columbia, Feb. 13, 2026 (GLOBE NEWSWIRE) -- SPARC AI Inc. (the “Company”) (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) today announced an upgraded release of SPARC AI Overwatch, enabling drones to continuously optimize the performance of their telemetry data using machine learning and AI models. Over time, Overwatch learns the behavior of each drone’s telemetry stream and applies correction to reduce targeting and navigation drift, improving accuracy, reliability and repeatability without requiring new hardware.
Agora, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 2, 2026SANTA CLARA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Agora, Inc. (
NASDAQ: API), a pioneer and leader in conversational AI and real-time engagement technology, will release its financial results for the fourth quarter and fiscal year ended December 31, 2025 after the close of U.S. markets on March 2, 2026. Agora, Inc. will host a conference call to discuss the financial results at 5 p.m. Pacific Time / 8 p.m. Eastern Time on the same day. Details for the conference call are as follows:
Prospect Credit REIT Outperforms Stanger Composite Net Asset Value REIT Index in 2025 with 13.14% Annualized Total Return and 9.00% Annualized Distribution RateNEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Since closing its first investment on February 6, 2025, through December 31, 2025, Prospect Credit REIT, LLC (“PCRED”), a non-traded real estate credit fund, achieved an annualized total return of 13.14% to investors.
Agencia Comercial Spirits Ltd Announces Entry Into Nonbinding Letters of Intent to Evaluate AI Computing Infrastructure and Data Center OpportunitiesTaichung City, Taiwan (R.O.C.), Feb. 13, 2026 (GLOBE NEWSWIRE) -- Agencia Comercial Spirits Ltd (
NASDAQ: AGCC) (the “Company” or “Agencia”), a Taiwan based importer and distributor of whisky products, announced today that it has entered into two separate nonbinding letters of intent as part of the Company’s evaluation of potential diversification into AI computing infrastructure and data center related opportunities, in addition to its existing whisky business.
Powell Max Limited Regains Compliance with NASDAQ Listing RequirementsHONG KONG, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) (the “Company” or “Powell Max”), a financial communications services provider headquartered in Hong Kong, is pleased to announce that it has successfully regained compliance with Nasdaq’s audit committee requirements, as stated in Listing Rule 5605(c)(2) (the “Rule”).
TC Energy reports fourth quarter and full-year 2025 resultsStrongest safety performance in five years drives 15 flow records and solid financial results
Gravity Reports Preliminary Unaudited 4Q 2025 Results and Business UpdatesSeoul, South Korea, Feb. 13, 2026 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games based in South Korea, today announced its unaudited financial results for the fourth quarter ended December 31, 2025, prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board and business updates.
Director/PDMR ShareholdingThe Magnum Ice Cream Company N.V.
Appliance GrandMasters Wins 2026 Most Professional Servicer AwardGreenville, SC, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Appliance GrandMasters, a family-owned appliance repair company based in Greenville, South Carolina, has been named the 2026 Most Professional Servicer Award winner by the United Appliance Servicers Association (UASA). The award was presented during the Annual Service Training Institute (ASTI) conference, held January 19–22, 2026, in Kansas City, Missouri.
Dentsu Announces New Global Management Structure– Further Contributing to Client Growth by Strengthening Execution Capabilities –
Norsk Hydro: Integrated Annual Report 2025: Increasing resilience to reach 2030 ambitions2025 was another year marked by geopolitical instability. Hydro’s geographic diversification and integrated value chain strengthens the resilience in navigating these challenges. Throughout 2025, Hydro implemented measures to increase agility and accelerate growth to achieve the strategic goals for 2030.
Sumitomo Forestry Announces Strategic Combination with Tri Pointe Homes to Create a Leading U.S. HomebuilderSupports expansion of affordable U.S. housing supply in addition to accelerating growth of Tri Pointe Homes’ high-quality homebuilding operations and providing U.S. homebuyers with a broader array of housing options
Norsk Hydro: Key information related to proposed cash dividendThe Board of Directors of Norsk Hydro ASA have decided to propose to the General Meeting a dividend of NOK 3.0 per share on the basis of the company's financial statements for the financial year 2025.
Norsk Hydro: Solid upstream performance driving strong cash flow generationHydro’s adjusted EBITDA for the fourth quarter of 2025 was NOK 5,587 million, down from NOK 7,701 million in the same quarter last year. The results decreased from lower realized alumina prices and a stronger NOK. This was partly offset by higher primary and alumina volumes and lower raw material costs. Hydro generated NOK 4.6 billion in free cash flow, while the twelve month adjusted RoaCE ended at 10.2 percent.
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary SharesLONDON and NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced the pricing of an underwritten public offering (the “Offering”) of 10,815,000 ordinary shares at an offering price of $1.85 per ordinary share. The Company has granted the underwriter a 30-day option to purchase up to an additional 1,622,250 ordinary shares at the public offering price, less underwriting discounts and commissions.
Iceberg Quantum unveils breakthrough in fault-tolerant quantum computingIts architecture solves the ‘overhead problem,’ reducing the physical qubits required for breaking RSA-2048 from millions to under 100,000
InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in ChinaBEIJING, Feb. 12, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the Phase II/III clinical trial of novel TYK2 inhibitor soficitinib (ICP-332) for the treatment of chronic spontaneous urticaria (CSU).
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common StockREDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (“Coherus” or the “Company”) (
NASDAQ: CHRS), today announced the pricing of an underwritten public offering of 28,600,000 shares of the Company’s common stock (the “Offering”). The shares of common stock are being sold at a public offering price of $1.75 per share, before underwriting discounts and commissions. All of the shares in the Offering are being sold by the Company. The gross proceeds to Coherus from the Offering are expected to be approximately $50.1 million, before deducting underwriting discounts and commissions and other offering expenses. The Company has granted the underwriters of the Offering a 30-day option to purchase up to an additional 4,290,000 shares of common stock at the public offering price, less the underwriting discounts and commissions. The Offering is expected to close on or about February 17, 2026, subject to the satisfaction of customary closing conditions.
URBANICA adds workstation privacy panels to help teams create focus zones in open plan officesLOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- URBANICA, a direct to consumer premium ergonomic office furniture brand, today announced the expansion of its workstation panel lineup to help teams build focus zones inside open plan offices without permanent construction. The new and expanded panel options are designed to reduce visual distractions, support calmer collaboration and create clearer boundaries in shared work areas, all while keeping layouts flexible for hybrid schedules and changing team sizes.
Namib Minerals Commences Dewatering at Redwing Mine in Support of Restart ProjectNEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), today provided an update on progress at its Redwing Mine in Zimbabwe, confirming that dewatering activities commenced on January 29, 2026, in line with the work plan outlined in the Company’s November 2025 business update. The dewatering phase will enable access to the mine for feasibility studies, including underground condition assessments and detailed engineering evaluations, which will inform the next stages of the restart project at Redwing.
IREN Added to MSCI USA IndexNEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- IREN Limited (
NASDAQ: IREN) (“IREN”) today announced it will be added to the MSCI USA Index, effective after close of trading on February 27, 2026.
An Update on Ring Partnership: Flock Safety Refocuses on Local Communities and InnovationAtlanta, GA, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Flock Safety, the leading safety technology platform dedicated to creating thriving communities, today announced it is pausing further exploration of a potential partnership with Ring.
21shares Announces Distributions on TSOLNEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced the following distribution for the 21shares Solana ETF (TSOL) for staking rewards earned from its SOL holdings.
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray MultipacksGAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions (
NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for new multipack configurations of over-the-counter (OTC) NARCAN® Nasal Spray. This approval expands the NARCAN® Nasal Spray product suite to include 6-count and 24-count multipack options, specifically designed to meet the needs of partners distributing higher volumes of naloxone. These new formats offer enhanced flexibility with the same trusted product, benefiting community programs and organizations operating large-scale, multi-site, or high-volume distribution programs.
PLUG SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Plug Power, Inc. Investors - Contact Kirby McInerney LLP by April 3, 2026NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Plug Power, Inc. (“Plug Power” or the “Company”) (
NASDAQ:PLUG) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Concentrix Prices $600 Million Senior Notes OfferingNEWARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (the “Company”) (
NASDAQ: CNXC), a global technology and services leader, today announced that it has priced a public offering of $600 million aggregate principal amount of 6.500% Senior Notes due 2029 (the “Offering”). The Company expects to use the net proceeds from the Offering, together with other available funds, as necessary, to redeem or otherwise repay at or prior to maturity all or a portion of its 6.650% Senior Notes due August 2, 2026 (the “2026 Notes”), of which $800 million aggregate principal amount is outstanding as of the date hereof, and pay related fees and expenses. The Offering is expected to close on February 24, 2026, subject to customary closing conditions.
Calian Reports on the Election of Directors Voting ResultsOTTAWA, Ontario, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The following matter was voted upon at the Annual Meeting of Shareholders of Calian® Group Ltd. (TSX:CGY), held on February 12, 2026, in Ottawa, Ontario. This and other matters voted upon are described in greater detail in the Notice of Annual Meeting of Shareholders and Management Proxy Circular dated December 15, 2025.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bath & Body Works and BellRing Brands and Encourages Investors to Contact the FirmNEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bath & Body Works, Inc. (
NYSE:BBWI) and BellRing Brands, Inc. (
NYSE:BRBR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Spartacus Acquisition Corp. II Announces Closing of $230,000,000 Initial Public OfferingAustin, TX, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Spartacus Acquisition Corp. II (the “Company”) announced today that it closed its initial public offering of 23,000,000 units, at $10.00 per unit, including 3,000,000 units pursuant to the full exercise of the overallotment option by the underwriters. The units began trading on the Nasdaq Capital Market (“Nasdaq”) on Wednesday, February 11, 2026 under the ticker symbol “TMTSU.” Each unit consists of one share of the Company’s Class A ordinary share and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, shares of the Class A ordinary share and warrants are expected to be listed on Nasdaq under the symbols “TMTS” and “TMTSW,” respectively.
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the fourth quarter and full year of 2025 before the open of trading on Friday, February 27, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET.
Bragar Eagel & Squire, P.C. Reminds Smart Digital Group Investors With Large Losses to Contact the Firm Regarding Their Rights Before March 16thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Smart Digital (SDM) To Contact Him Directly To Discuss Their Options.
EverCommerce Announces Date of Fourth Quarter 2025 Earnings CallDENVER, Feb. 12, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. (
NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, will report its fourth quarter 2025 financial results after the U.S. financial markets close on Thursday, March 12, 2026.
Interfor Reports Q4’25 ResultsAdjusted EBITDA loss of $29 million and Net Loss of $105 million
Parker Scheduled to Present at Citi’s 2026 Global Industrial Tech and Mobility Conference on February 19 at 11:20 a.m. Eastern TimeCLEVELAND, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (
NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at Citi’s 2026 Global Industrial Tech and Mobility Conference in Miami, Florida on February 19, 2026 at 11:20 a.m. Eastern time. A live webcast of the presentation will be accessible on Parker's investor information website at investors.parker.com and will be archived on the site.
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
KYNDRYL HOLDINGS, INC. (KD) INVESTOR ALERT Investors With Large Losses in Kyndryl Holdings, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsNEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (
NYSE: KD) between August 7, 2024 and February 9, 2025, inclusive.
D. Boral Acquisition I Corp. Announces Closing of $287,500,000 Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment OptionNew York, NY, Feb. 12, 2026 (GLOBE NEWSWIRE) -- D. Boral Acquisition I Corp. (the “Company”) today announced the closing of its initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, at a price of $10.00 per unit for total gross proceeds of $287,500,000. The units began trading on The Nasdaq Global Market under the ticker symbol “DBCAU” on February 11, 2026. Each unit consists of one of the Company’s Class A ordinary shares and one-half of one redeemable public warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be traded on The Nasdaq Global Market under the symbols “DBCA” and “DBCAW,” respectively. The Company intends to use the net proceeds from the offering and the simultaneous private placement of units to pursue and consummate a business combination with one or more businesses.
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report fourth quarter and full year 2025 financial and business results after the market closes on Tuesday, February 24, 2026.
CORRECTION: AIM ImmunoTech Announces Commencement of Rights OfferingThis press release is issued solely to correct a date from an AIM press release dated February 11, 2026. The Subscription Rights will expire if they are not exercised by 5:00 p.m., Eastern Time, on February 27, 2026, the expected expiration date of the Rights Offering.
MONAT Unleashed Ignites Munich: Over 800 Market Partners Gather at BMW Welt for a Powerful Celebration of Growth Across EuropeMUNICH, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Energy, innovation, and European momentum took center stage as more than 800 MONAT Market Partners from across Germany, Austria, and surrounding markets gathered at the ultra-modern BMW Welt & Museum for MONAT Unleashed Germany. The brand’s first major event since expanding into Germany eight months ago made a powerful statement of growth, innovation, and renewed connection.
Voodoo Doughnut to Open First Miami Location on February 19thLegendary doughnut shop celebrates its Miami debut with free doughnuts, opening-day giveaways, and a partnership supporting NAMI Miami-Dade.
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring TechnologiesCollaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product
GB Capital Ltd. Co-Advises on the Acquisition of SVM Machining, Inc.VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- GB Capital Ltd. (“GB Capital”), a strategic finance, advisory and management firm, today announced that it served as co-advisor to PMGC Holdings Inc. (
NASDAQ: ELAB) (“PMGC”) in connection with PMGC’s acquisition of SVM Machining, Inc. (“SVM”), a Northern California–based ISO 9001:2015 certified CNC precision machining company.
Rocket Lab Prepares To Launch Latest Hypersonic Test Mission for Defense Innovation UnitLONG BEACH, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced its next launch is a dedicated mission on its HASTE rocket for the Department of War’s Defense Innovation Unit (DIU).
Wix to Announce Fourth Quarter and Full Year 2025 Earnings Results on March 4, 2026NEW YORK -- Wix.com Ltd. (Nasdaq: WIX), today announced that it will report its results for the fourth quarter and full year ended December 31, 2025 before the market opens on Wednesday, March 4, 2026. Management will host a conference call and webcast that morning at 8:30 a.m. ET to answer questions about the Company's financial results. Prior to the conference call and webcast, Wix will issue a press release reporting these results along with a shareholder update and additional materials at https://investors.wix.com/.
